Pharmaceutical Technology Europe - October 2012 - (Page 9)
NEWS BITES
Your Voice
Latest survey results from PharmTech.com/Polls The European Generic Medicines Agency has recently claimed that the potential fees to be charged by the European Medicines Agency for pharmacovigilance activities are unjustifiably high. Do you agree?
Trends
@PharmTechGroup Watson Issues Voluntary Recall of Combination Drug http://ht.ly/e1PCX @ChemistryWorld Jerome Horwitz developer of the first HIV drug AZT has died. ‘One of academia’s most under-recognized inventors’ http://lat.ms/UxXVWr @PharmExecutive Don’t forget about our Pharm Exec Global Digest! http://bit.ly/RWkvXg @BioPharmIntl US National park to serve as a giant laboratory for rare disease ow.ly/e1P0D @AstraZeneca New post on #LabTalk: The #Alzheimer’s challenge: on the way to discovery http://ow.ly/e3UU3 @blogaceutics German doctors criticise EU clinical trial reform plans ow.ly/e3OX4
Yes 61% No 29% The wording of the fees is not clear 10%
Want to discuss these poll results? Why not join our ever-expanding LinkedIn community at PharmTech.com/LinkedIn
@MarkHfierce Picture a medical device that dissolves @PharmTechGroup Pharma, healthy eating, chocolate and in your body after its work is done. That’s coming sooner than you think. the F1 Grand Prix - GSK’s new deal http://n.pr/SgShXt http://ht.ly/dSGOy Follow us on twitter at PharmTech.com/Twitter
2 OUTSOURCING 11 REGULATORY COOPERATION
7 QUALITY BY DESIGN 12 COCRYSTALS
8 NEWS 13 BLOGS
10 ENERGY EFFICIENCY 15 STAFF
http://www.PharmTech.com/Pollshttp://ht.ly/e1PCXhttp://ow.ly/e1P0Dhttp://ow.ly/e3UU3http://lat.ms/UxXVWrhttp://ow.ly/e3OX4http://bit.ly/RWkvXghttp://www.PharmTech.com/LinkedInhttp://ht.ly/dSGOyhttp://n.pr/SgShXthttp://www.PharmTech.com/Twitter
Table of Contents for the Digital Edition of Pharmaceutical Technology Europe - October 2012